MAB159SP

Drosophila Decapentaplegic/DPP Antibody, R&D Systems™

Manufacturer: R&D Systems

Select a Size

Pack Size SKU Availability Price
Each of 1 MAB159SP-Each-of-1 In Stock ₹ 17,154.78

MAB159SP - Each of 1

₹ 17,154.78

In Stock

Quantity

1

Base Price: ₹ 17,154.78

GST (18%): ₹ 3,087.86

Total Price: ₹ 20,242.64

Antigen

Decapentaplegic/DPP

Classification

Monoclonal

Concentration

LYOPH

Dilution

Western Blot 1 ug/mL

Gene Accession No.

NP_722813.1

Immunogen

E. coli-derived recombinantDrosophilaDecapentaplegic/DPP Asp457-Arg588 (Gln473His, Pro474Ala) Accession # NP_722813.1

Quantity

25 μg

Primary or Secondary

Primary

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Isotype

IgG2b

Applications

Western Blot

Clone

146609

Conjugate

Unconjugated

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Host Species

Mouse

Purification Method

Protein A or G purified from hybridoma culture supernatant

Regulatory Status

RUO

Test Specificity

DetectsDrosophilaDecapentaplegic/DPP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TGF-alpha , rhTGF-beta 1, rhTGF-beta 1.2, rhTGF-beta 2, rhTGF-beta 3, rhLAP, recombinant porcine (rp) TGF-beta 1.2, rpTGF-beta 2, or recombinant amphibian TGF-beta 5 is observed.

Target Species

Drosophila

Form

Purified

Related Products

Img

R&D Systems

MAB159

--

Img

R&D Systems

MAB2824SP

--

Img

R&D Systems

MAB2824

--

Img

R&D Systems

MAB346SP

--

Img

R&D Systems

MAB2098SP

--

Img

R&D Systems

MAB20471

--

Img

R&D Systems

MAB1744SP

--

Img

R&D Systems

MAB3127SP

--

Description

  • Decapentaplegic/DPP Monoclonal specifically detects Decapentaplegic/DPP in Drosophila samples
  • It is validated for Western Blot.

Compare Similar Items

Show Difference

Img

R&D Systems

MAB159SP

--


Antigen:
Decapentaplegic/DPP

Classification:
Monoclonal

Concentration:
LYOPH

Dilution:
Western Blot 1 ug/mL

Gene Accession No.:
NP_722813.1

Immunogen:
E. coli-derived recombinantDrosophilaDecapentaplegic/DPP Asp457-Arg588 (Gln473His, Pro474Ala) Accession # NP_722813.1

Quantity:
25 μg

Primary or Secondary:
Primary

Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Isotype:
IgG2b

Applications:
Western Blot

Clone:
146609

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Host Species:
Mouse

Purification Method:
Protein A or G purified from hybridoma culture supernatant

Regulatory Status:
RUO

Test Specificity:
DetectsDrosophilaDecapentaplegic/DPP in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TGF-alpha , rhTGF-beta 1, rhTGF-beta 1.2, rhTGF-beta 2, rhTGF-beta 3, rhLAP, recombinant porcine (rp) TGF-beta 1.2, rpTGF-beta 2, or recombinant amphibian TGF-beta 5 is observed.

Target Species:
Drosophila

Form:
Purified

Img

R&D Systems

MAB160100

--


Antigen:
CXCR3

Classification:
Monoclonal

Concentration:
LYOPH

Dilution:
Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 8-25 ug/mL, Neutralization 0.3-1.5 ug/mL, CyTOF-ready

Gene Accession No.:
P49682

Immunogen:
NS0 mouse myeloma cell line transfected with human CXCR3 Met1-Leu368 Accession # P49682

Quantity:
100 μg

Primary or Secondary:
Primary

Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Isotype:
IgG1

Applications:
Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF

Clone:
49801

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS and NaCl with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Host Species:
Mouse

Purification Method:
Protein A or G purified from ascites

Regulatory Status:
RUO

Test Specificity:
Detects human CXCR3.

Target Species:
Human

Form:
Purified

Img

R&D Systems

MAB1603

--


Antigen:
VEGF

Classification:
Monoclonal

Concentration:
__

Dilution:
Western Blot 1 ug/mL, Immunocytochemistry 8-25 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Gene Accession No.:
NP_001103972

Immunogen:
E. coli-derived recombinant canine VEGF 164 Pro28-Arg190 Accession # NP_001103972

Quantity:
500 μg

Primary or Secondary:
Primary

Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Isotype:
IgG1

Applications:
Western Blot, Immunocytochemistry, ELISA

Clone:
247109

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Host Species:
Mouse

Purification Method:
Protein A or G purified from hybridoma culture supernatant

Regulatory Status:
RUO

Test Specificity:
Detects canine VEGF in ELISAs and Western blots. In sandwich immunoassays, 100% cross-reactivity with recombinant human (rh) VEGF 121 and rhVEGF 165 less than 25% cross-reactivity with recombinant rat VEGF 164 and no cross-reactivity with rhVEGF-B 186 rhVEGF-C, rhVEGF-D, recombinant mouse (rm) VEGF 115 rmVEGF 120 rmVEGF 165 or recombinant zebrafish VEGF 165 is observed.

Target Species:
Canine

Form:
Purified

Img

R&D Systems

MAB1603SP

--


Antigen:
VEGF

Classification:
Monoclonal

Concentration:
__

Dilution:
Western Blot 1 ug/mL, Immunocytochemistry 8-25 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Gene Accession No.:
NP_001103972

Immunogen:
E. coli-derived recombinant canine VEGF 164 Pro28-Arg190 Accession # NP_001103972

Quantity:
25 μg

Primary or Secondary:
Primary

Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.

Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Isotype:
IgG1

Applications:
Western Blot, Immunocytochemistry, ELISA

Clone:
247109

Conjugate:
Unconjugated

Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Host Species:
Mouse

Purification Method:
Protein A or G purified from hybridoma culture supernatant

Regulatory Status:
RUO

Test Specificity:
Detects canine VEGF in ELISAs and Western blots. In sandwich immunoassays, 100% cross-reactivity with recombinant human (rh) VEGF 121 and rhVEGF 165 less than 25% cross-reactivity with recombinant rat VEGF 164 and no cross-reactivity with rhVEGF-B 186 rhVEGF-C, rhVEGF-D, recombinant mouse (rm) VEGF 115 rmVEGF 120 rmVEGF 165 or recombinant zebrafish VEGF 165 is observed.

Target Species:
Canine

Form:
Purified